, Tracking Stock Market Picks
Enter Symbol:
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

Neutral REGN
up 8.52 %

Regeneron Pharmaceuticals, Inc. (REGN) downgraded to Neutral with price target $565 by Chardan Capital Markets

Posted on: Monday,  Aug 31, 2015  8:25 AM ET by Chardan Capital Markets

Chardan Capital Markets rated Neutral Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 08/31/2015. Previously Chardan Capital Markets rated Buy Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)
on 03/20/2015., when the stock price was $491.85. Since then, Regeneron Pharmaceuticals, Inc. has gained 8.53% as of 08/31/2015's recent price of $533.80.
If you would have followed the previous Chardan Capital Markets's recommendation on REGN, you would have gained 8.52% of your investment in 164 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

Chardan Capital Markets
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/31/2015 8:25 AM Hold
533.80 565.00
as of 8/27/2015
1 Week down  -7.08 %
1 Month up  3.25 %
3 Months up  9.47 %
1 YTD up  9.38 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/20/2015 8:25 AM Buy
491.85 560.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy